Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Ye YX, Calcagno C, Binderup T, Courties G, Keliher EJ, Wojtkiewicz GR, Iwamoto Y, Tang J, Pérez-Medina C, Mani V, Ishino S, Johnbeck CB, Knigge U, Fayad ZA, Libby P, Weissleder R, Tawakol A, Dubey S, Belanger AP, Di Carli MF, Swirski FK, Kjaer A, Mulder WJ, Nahrendorf M. Ye YX, et al. Among authors: tawakol a. Circ Res. 2015 Oct 23;117(10):835-45. doi: 10.1161/CIRCRESAHA.115.307024. Epub 2015 Sep 22. Circ Res. 2015. PMID: 26394773 Free PMC article.
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, Burgess T, Fuster V, Rudd JH, Tawakol A, Farkouh ME. Fayad ZA, et al. Among authors: tawakol a. Am Heart J. 2011 Aug;162(2):214-221.e2. doi: 10.1016/j.ahj.2011.05.006. Am Heart J. 2011. PMID: 21835280 Free PMC article. Clinical Trial.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.
Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A; dal-PLAQUE Investigators. Fayad ZA, et al. Among authors: tawakol a. Lancet. 2011 Oct 29;378(9802):1547-59. doi: 10.1016/S0140-6736(11)61383-4. Epub 2011 Sep 9. Lancet. 2011. PMID: 21908036 Free PMC article. Clinical Trial.
Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, Hoffmann U, Brady TJ, Tawakol A. Figueroa AL, et al. Among authors: tawakol a. Circ Cardiovasc Imaging. 2012 Jan;5(1):69-77. doi: 10.1161/CIRCIMAGING.110.959478. Epub 2011 Oct 28. Circ Cardiovasc Imaging. 2012. PMID: 22038986
PET/MRI of inflammation in myocardial infarction.
Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, Dutta P, Iwamoto Y, Ueno T, Begieneman MP, Niessen HW, Piek JJ, Vinegoni C, Pittet MJ, Swirski FK, Tawakol A, Di Carli M, Weissleder R, Nahrendorf M. Lee WW, et al. Among authors: tawakol a. J Am Coll Cardiol. 2012 Jan 10;59(2):153-63. doi: 10.1016/j.jacc.2011.08.066. J Am Coll Cardiol. 2012. PMID: 22222080 Free PMC article.
Aortic distensibility and its relationship to coronary and thoracic atherosclerosis plaque and morphology by MDCT: insights from the ROMICAT Trial.
Siegel E, Thai WE, Techasith T, Major G, Szymonifka J, Tawakol A, Nagurney JT, Hoffmann U, Truong QA. Siegel E, et al. Among authors: tawakol a. Int J Cardiol. 2013 Aug 20;167(4):1616-21. doi: 10.1016/j.ijcard.2012.04.107. Epub 2012 May 10. Int J Cardiol. 2013. PMID: 22578738 Free PMC article. Clinical Trial.
195 results